Evidence map›Paper›PMID 21251012›Full record

ReviewAnnals of the New York Academy of Sciences2011

B cell receptor editing in tolerance and autoimmunity.

Eline T Luning Prak, Marc Monestier, Robert A Eisenberg

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 99 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Eline T Luning PrakDepartment of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. luning@mail.med.upenn.edu
Marc Monestier
Robert A Eisenberg
University of Pennsylvania · USTemple University · US

Funding

B-Lymphocyte Immunotherapy in Islet TransplantationU01DK070430 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NAJI, ALI · 2004 to 2011
$10.1M
EXPERIMENTAL INDUCTION OF SLE BY ALTERED IAR01AR034156 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI LUNING PRAK, ELINE TJETSKE · 1986 to 2012
$3.5M
B Cells in Murine Sjogren's SyndromeR01DE017590 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI COHEN, PHILIP L · 2006 to 2010
$2.4M
Mechanisms of autoreactivity in SLER01AI063626 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI EISENBERG, ROBERT A. · 2005 to 2009
$1.6M
IMMUNOTOXICOLOGIC EFFECTS OF MERCURY ON B CELLSR01ES012464 · NIEHS · TEMPLE UNIV OF THE COMMONWEALTH · PI MONESTIER, MARC · 2003 to 2007
$1.6M
Immune correlates of steroid responsiveness in ITPR56AI090842 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LUNING PRAK, ELINE TJETSKE · 2010 to 2010
$404k
Pediatric Secondhand Smoke Exposure Reduction StrategiesR13ES012646 · NIEHS · CHILDREN'S RESEARCH INSTITUTE · PI BEST, DANA · 2004 to 2004
$12k
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050024N01AI050024 · NIAID · THE CHILDRENS HOSPITAL OF PHI · PI SULLIVAN, KATHLEEN · 2006 to 2006
–
NIAID NIH HHS N01 AI050024NIAID NIH HHS R01 AI063626NIAID NIH HHS R01-AI63626NIAID NIH HHS R56 AI090842NIAID NIH HHS R56-AI090842NIAMS NIH HHS R01 AR034156NIAMS NIH HHS R01-AR34156NIDCR NIH HHS R01 DE017590NIDDK NIH HHS U01 DK070430NIEHS NIH HHS ES-12646NIEHS NIH HHS R01 ES012464NIEHS NIH HHS R13 ES012646
6 · The paper itself

Abstract

Receptor editing is the process of ongoing antibody gene rearrangement in a lymphocyte that already has a functional antigen receptor. The expression of a functional antigen receptor will normally terminate further rearrangement (allelic exclusion). However, lymphocytes with autoreactive receptors have a chance at escaping negative regulation by "editing" the specificities of their receptors with additional antibody gene rearrangements. As such, editing complicates the Clonal Selection Hypothesis because edited cells are not simply endowed for life with a single, invariant antigen receptor. Furthermore, if the initial immunoglobulin gene is not inactivated during the editing process, allelic exclusion is violated and the B cell can exhibit two specificities. Here, we describe the discovery of editing, the pathways of receptor editing at the heavy (H) and light (L) chain loci, and current evidence regarding how and where editing happens and what effects it has on the antibody repertoire.

Indexed as

Immune ToleranceAnimalsAutoimmune DiseasesGene Rearrangement, B-LymphocyteHumansReceptors, Antigen, B-CellSignal TransductionReceptors, Antigen, B-Cell

Identifiers

PMID21251012
PMCPMC3077556
OpenAlexW1538595011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.